NYSE:TFX

Teleflex Stock Forecast, Price & News

$396.87
-6.16 (-1.53 %)
(As of 06/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$393.67
$402.71
50-Day Range
$385.96
$443.85
52-Week Range
$312.33
$449.38
Volume530,988 shs
Average Volume210,922 shs
Market Capitalization$18.55 billion
P/E Ratio67.38
Dividend Yield0.34%
Beta1.18
30 days | 90 days | 365 days | Advanced Chart
Receive TFX News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.


Teleflex logo

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology product comprises the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

2.01 out of 5 stars

Medical Sector

79th out of 2,100 stocks

Surgical & Medical Instruments Industry

7th out of 174 stocks

Analyst Opinion: 2.6Community Rank: 2.3Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Teleflex (NYSE:TFX) Frequently Asked Questions

Is Teleflex a buy right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last twelve months. There are currently 9 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Teleflex stock.
View analyst ratings for Teleflex
or view top-rated stocks.

What stocks does MarketBeat like better than Teleflex?

Wall Street analysts have given Teleflex a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Teleflex wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Teleflex's next earnings date?

Teleflex is scheduled to release its next quarterly earnings announcement on Thursday, July 29th 2021.
View our earnings forecast for Teleflex
.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) announced its earnings results on Thursday, April, 29th. The medical technology company reported $2.87 EPS for the quarter, beating the consensus estimate of $2.44 by $0.43. The medical technology company had revenue of $633.93 million for the quarter, compared to the consensus estimate of $621.28 million. Teleflex had a net margin of 10.98% and a trailing twelve-month return on equity of 15.71%.
View Teleflex's earnings history
.

How has Teleflex's stock price been impacted by Coronavirus (COVID-19)?

Teleflex's stock was trading at $342.08 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, TFX shares have increased by 16.0% and is now trading at $396.87.
View which stocks have been most impacted by COVID-19
.

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex announced a quarterly dividend on Monday, May 3rd. Shareholders of record on Friday, May 14th will be given a dividend of $0.34 per share on Tuesday, June 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.34%. The ex-dividend date of this dividend is Thursday, May 13th.
View Teleflex's dividend history
.

Is Teleflex a good dividend stock?

Teleflex pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.34%. Teleflex does not yet have a strong track record of dividend growth. The dividend payout ratio of Teleflex is 12.75%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Teleflex will have a dividend payout ratio of 9.15% next year. This indicates that Teleflex will be able to sustain or increase its dividend.
View Teleflex's dividend history.

What guidance has Teleflex issued on next quarter's earnings?

Teleflex issued an update on its FY 2021 earnings guidance on Tuesday, June, 15th. The company provided earnings per share guidance of $12.650-12.850 for the period, compared to the Thomson Reuters consensus estimate of $12.770. The company issued revenue guidance of -.

What price target have analysts set for TFX?

10 equities research analysts have issued 12-month price targets for Teleflex's shares. Their forecasts range from $440.00 to $485.00. On average, they anticipate Teleflex's share price to reach $462.90 in the next twelve months. This suggests a possible upside of 16.6% from the stock's current price.
View analysts' price targets for Teleflex
or view top-rated stocks among Wall Street analysts.

Who are Teleflex's key executives?

Teleflex's management team includes the following people:
  • Mr. Liam J. Kelly, Chairman, Pres & CEO (Age 54, Pay $2.01M)
  • Mr. Thomas E. Powell, Exec. VP & CFO (Age 59, Pay $1.08M)
  • Mr. Cameron P. Hicks, Corp. VP & Chief HR Officer (Age 56, Pay $543.81k)
  • Mr. James P. Winters, Corp. VP, Manufacturing and Supply Chain
  • Mr. John R. Deren, VP & Chief Accounting Officer
  • Mr. Timothy F. Duffy, VP & Chief Information Officer
  • Mr. John Hsu C.F.A., VP of Investor Relations
  • Ms. Gwen Chapman, Chief Compliance Officer & Corp. VP (Age 46)
  • Mr. Daniel V. Logue, Corp. VP, Gen. Counsel & Sec. (Age 47)
  • Mr. James Ferguson, Pres & GM of Surgical - Latin America

What is Liam Kelly's approval rating as Teleflex's CEO?

73 employees have rated Teleflex CEO Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among Teleflex's employees.

Who are some of Teleflex's key competitors?

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), salesforce.com (CRM) and Cisco Systems (CSCO).

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Who are Teleflex's major shareholders?

Teleflex's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.80%), Price T Rowe Associates Inc. MD (10.64%), Janus Henderson Group PLC (2.13%), Geode Capital Management LLC (1.64%), Bank of New York Mellon Corp (1.45%) and Franklin Resources Inc. (1.33%). Company insiders that own Teleflex stock include Benson Smith, Cameron P Hicks, James J Leyden, John Deren, Karen Boylan, Stephen K MD Klasko, Stuart A Randle and Thomas E Powell.
View institutional ownership trends for Teleflex
.

Which institutional investors are selling Teleflex stock?

TFX stock was sold by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, Montag & Caldwell LLC, Strs Ohio, Principal Financial Group Inc., Principal Financial Group Inc., Franklin Resources Inc., State of Tennessee Treasury Department, and Bank of Montreal Can. Company insiders that have sold Teleflex company stock in the last year include Cameron P Hicks, Stephen K MD Klasko, and Stuart A Randle.
View insider buying and selling activity for Teleflex
or view top insider-selling stocks.

Which institutional investors are buying Teleflex stock?

TFX stock was acquired by a variety of institutional investors in the last quarter, including Oak Ridge Investments LLC, Morgan Stanley, Janus Henderson Group PLC, Point72 Asset Management L.P., BlackRock Inc., Alyeska Investment Group L.P., FIL Ltd, and BNP Paribas Arbitrage SA.
View insider buying and selling activity for Teleflex
or or view top insider-buying stocks.

How do I buy shares of Teleflex?

Shares of TFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $396.87.

How much money does Teleflex make?

Teleflex has a market capitalization of $18.55 billion and generates $2.54 billion in revenue each year. The medical technology company earns $335.32 million in net income (profit) each year or $10.67 on an earnings per share basis.

How many employees does Teleflex have?

Teleflex employs 14,000 workers across the globe.

When was Teleflex founded?

Teleflex was founded in 1943.

What is Teleflex's official website?

The official website for Teleflex is www.teleflex.com.

Where are Teleflex's headquarters?

Teleflex is headquartered at 550 E SWEDESFORD RD, WAYNE PA, 19087.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The medical technology company can be reached via phone at 610-225-6800 or via email at [email protected]


This page was last updated on 6/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.